← FDA DRUG APPROVALS

FDA ANDA · ANDA074288

ACEBUTOLOL HYDROCHLORIDE

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA074288
TYPE
ANDA
ORIGINAL APPROVAL
1995-04-24
LATEST ACTION
2014-03-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

ACEBUTOLOL HYDROCHLORIDEDiscontinued
ACEBUTOLOL HYDROCHLORIDE EQ 400MG BASE · CAPSULE · ORAL
ACEBUTOLOL HYDROCHLORIDEDiscontinued
ACEBUTOLOL HYDROCHLORIDE EQ 200MG BASE · CAPSULE · ORAL

Approval history

2014-03-28Manufacturing (CMC) · Supplement 10 · unknownAP
2014-03-26Labeling · Supplement 9 · standardAP
1999-11-04Labeling · Supplement 3AP
1998-06-23Labeling · Supplement 2AP
1998-02-05Manufacturing (CMC) · Supplement 1AP
1995-04-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →